Repositioning Candidates

Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.

stats1
stats2
stats3

Search for:

     Toll-like receptor 4
12 records.
Candidate ID Source ID Source Type Compound Type Candidate Name Inclusion Criteria
R0334 DB00924 approved small molecule Cyclobenzaprine Target associated Details
R0437 DB01183 approved; vet_approved small molecule Naloxone Target associated Details
R0571 DB02767 experimental small molecule (R)-3-hydroxytetradecanoic acid Target associated Details
R0574 DB03017 approved; experimental small molecule Lauric acid Target associated Details
R0653 DB04933 investigational small molecule Eritoran Target associated Details
R0811 DB05475 investigational small molecule Golotimod Target associated Details
R0902 DB05943 investigational small molecule Resatorvid Therapeutic strategy associated Details
R1017 DB06447 investigational small molecule E5531 Target associated Details
R1140 DB08231 experimental small molecule Myristic acid Target associated Details
R1290 DB09301 approved; investigational; nutraceutical small molecule Chondroitin sulfate Therapeutic strategy associated Details
R1347 DB11193 approved small molecule Papain Therapeutic strategy associated Details
R1492 DB13615 approved; experimental small molecule Mifamurtide Therapeutic strategy associated Details